Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Self-Presentation

Self-Presentation

Self-presentation is a fundamental aspect of social interaction, shaping both how others perceive individuals and how they view themselves. This dynamic process influences behaviors in various social settings, often leading people to adjust their appearance, speech, and demeanor to align with their desired identity. While self-presentation can be deliberate or unconscious, it plays a critical role in interpersonal relationships and self-perception.Forms of Self-PresentationSelf-presentation can...

Conformity

Conformity

Conformity is the change in a person’s behavior to go along with the group, even if that person does not agree with the group.

Data Collection II

Data Collection II

The nursing history captures and records the patient's health status, so that a care plan evolves to meet the patient's individual needs. The nursing health history is a part of the initial assessment. A comprehensive history covers all health dimensions and plays a significant role in the assessment process. A comprehensive history includes the patient's biographical information, reasons for seeking health care, expectations, present and past health history, medications, and family,...

Crossing Over

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...

Crossing Over

Crossing Over

Crossing over is the exchange of genetic information between homologous chromosomes during prophase I of meiosis I. Genetic recombination gives rise to allelic diversity in the newly formed daughter cells. In humans, crossing over produces genetically distinct haploid egg and sperm cells that undergo fertilization to produce unique offspring. Before cell division starts, the germ cell’s chromosome(s) undergo duplication in the S phase of the cell cycle. As the cells enter prophase I, duplicated...

Crossing over

Crossing over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process called synapsis.
In order to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Discovery of VU6053371/BI03738809: A First-in-Class Selective and CNS-Penetrant mGlu<sub>3</sub> Positive Allosteric Modulator (PAM) with Efficacy in a Preclinical Cognition Model.

ACS chemical neuroscience·2026

Same author

Discovery of 7-(Pyridin-3-yl)thieno[3,2-<i>b</i>]pyridine-5-carboxamides as Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5.

ACS chemical neuroscience·2026

Same author

Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M<sub>4</sub> Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust <i>In Vivo</i> Efficacy.

ACS chemical neuroscience·2026

Same author

Discovery of VU6052254: A Novel, Potent M<sub>1</sub> Positive Allosteric Modulator.

ACS chemical neuroscience·2025

Same author

Muscarinic Acetylcholine Receptor Activators as Transformative Therapeutics for Schizophrenia.

Annual review of medicine·2025

Same author

Investigating the role of rostral pedunculopontine nucleus M<sub>4</sub> receptors in motor deficits and dyskinesia in hemiparkinsonian rats.

Behavioural brain research·2025

Search research articles

Related Experiment Video

Updated: May 8, 2026

Microbial Communities in Nature and Laboratory - Interview

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

Interview: interview with P Jeffrey Conn. Interview by Hannah Coaker.

P Jeffrey Conn¹

¹Department of Pharmacology, Vanderbilt University Medical Center, 23rd Avenue South at Pierce, 417-D Preston Research Building, Nashville, TN 37232-6600, USA. jeff.conn@vanderbilt.edu.

Future Medicinal Chemistry

|September 13, 2013

Summary

Dr. Conn leads the Vanderbilt Center for Neuroscience Drug Discovery, focusing on translating basic science into new treatments for brain disorders like schizophrenia and Parkinson's disease.

More Related Videos

Investigating the Microbial Community in the Termite Hindgut - Interview

Investigating the Microbial Community in the Termite Hindgut - Interview

Published on: May 28, 2007

Biology of Microbial Communities - Interview

Biology of Microbial Communities - Interview

Published on: May 28, 2007

Related Experiment Videos

Last Updated: May 8, 2026

Microbial Communities in Nature and Laboratory - Interview

Microbial Communities in Nature and Laboratory - Interview

Published on: May 28, 2007

Investigating the Microbial Community in the Termite Hindgut - Interview

Investigating the Microbial Community in the Termite Hindgut - Interview

Published on: May 28, 2007

Biology of Microbial Communities - Interview

Biology of Microbial Communities - Interview

Published on: May 28, 2007

Area of Science:

Neuroscience
Pharmacology
Drug Discovery

Background:

Dr. Conn, Director of the Vanderbilt Center for Neuroscience Drug Discovery (VCNDD), has a strong background in pharmacology and neuroscience research.
He previously held positions at Emory University and Merck & Co., focusing on neuroscience drug development.

Discussion:

The VCNDD's mission is to bridge the gap between basic scientific advancements and the development of novel therapeutics.
The center comprises approximately 100 scientists dedicated to advancing drug discovery programs.

Key Insights:

The VCNDD has successfully advanced novel molecules from four major programs into development candidates for clinical testing.
This translational approach involves collaboration with industry partners.

Outlook:

Current research efforts are concentrated on developing innovative treatment strategies for serious brain disorders, including schizophrenia and Parkinson's disease.
Dr. Conn's work aims to impact patient outcomes through targeted therapeutic interventions.